Notice of Effectiveness (effect)
June 07 2017 - 6:01AM
Edgar (US Regulatory)
|
UNITED STATES
|
|
SECURITIES AND EXCHANGE COMMISSION
|
|
Washington, D.C. 20549
|
NOTICE OF EFFECTIVENESS
|
|
|
|
Effective Date:
|
June 06,
2017
|
|
Form:
|
S-4
|
|
CIK:
|
0001626199
|
|
Company Name:
|
Nivalis Therapeutics, Inc.
|
|
File Number:
|
333-218134
|
Alpine Immune Sciences (NASDAQ:ALPN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alpine Immune Sciences (NASDAQ:ALPN)
Historical Stock Chart
From Sep 2023 to Sep 2024
